Please assess the completion status of the following clinical trial:

Trial Title: Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* A total body weight \>25 kg (55 lbs).~* Symptoms of urinary frequency (average ≥8 daily bathroom visits to urinate) and urgency to urinate, with or without urgency incontinence, for at least 6 months prior to enrolment, OR~* Stable neurological disease and urodynamically confirmed detrusor overactivity, who may require intermittent catheterization for management of urinary drainage.~Exclusion Criteria:~* Treatment with an investigational drug within 4 weeks or 5 half-lives, whichever is longer, before first study dose~* Ongoing use of potent CYP3A4 inhibitors or inducers or CYP2D6 inhibitors~* Ongoing use of another drug for treating overactive bladder~* Uncontrolled narrow angle glaucoma, urinary or gastric retention

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Fesoterodine once daily (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).